{"reporting_entity_name": "GIIC_TPA","reporting_entity_type": "GIIC_Geisinger Indemnity Insurance Company","last_updated_on": "2026-10-07","version": "2.0","provider_references": [ {"provider_group_id":1329967957,"network_name":[],"provider_groups":[{"npi":[1003170937,1013384809,1033491741,1063540011,1063708501,1093555120,1154617694,1235215427,1245632231,1275832164,1275850620,1417231937,1427344969,1457181422,1457650343,1467748475,1518281039,1528197720,1538391248,1659762862,1669768289,1770879215,1790128254,1801418306,1851508162,1962583922,1982037966,1982988408],"tin":{"type":"ein","value":"240795959","business_name":"Geisinger Medical Center"}}]} ], "in_network" : [ {"negotiation_arrangement":"ffs","name":"Cont ambulatory peritoneal dialysis-capd/composite or other rate","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0841","description":"Cont ambulatory peritoneal dialysis-capd/composite or other rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"negotiated","negotiated_rate":13999.92,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Pharmacy","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0250","description":"Pharmacy","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":1101.7,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Pharmacy","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0250","description":"Pharmacy","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":1101.7,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Pharmacy","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0250","description":"Pharmacy","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":845.1,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Cont ambulatory peritoneal dialysis (capd) - support services","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0845","description":"Cont ambulatory peritoneal dialysis (capd) - support services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"negotiated","negotiated_rate":13999.92,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Drugs requiring specific ident - drugs requiring detailed coding","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0636","description":"Drugs requiring specific ident - drugs requiring detailed coding","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":1025.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Drugs requiring specific ident - drugs requiring detailed coding","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0636","description":"Drugs requiring specific ident - drugs requiring detailed coding","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":917.35,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Drugs requiring specific ident - drugs requiring detailed coding","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0636","description":"Drugs requiring specific ident - drugs requiring detailed coding","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":1092.48,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Cont cycling peritoneal dialysis - ccpd/composite or other rate","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0851","description":"Cont cycling peritoneal dialysis - ccpd/composite or other rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"negotiated","negotiated_rate":13999.92,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Continuous cycling peritoneal dialysis (ccpd) - support services","billing_code_type":"RC","billing_code_type_version":"2024","billing_code":"0855","description":"Continuous cycling peritoneal dialysis (ccpd) - support services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"negotiated","negotiated_rate":13999.92,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Injection_ teprotumumab-trbw_ 10 mg","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"J3241","description":"Injection_ teprotumumab-trbw_ 10 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":389.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Injection_ nusinersen_ 0.1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"J2326","description":"Injection_ nusinersen_ 0.1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":135000.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Robotic surgical system","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"S2900","description":"Robotic surgical system","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"percentage","negotiated_rate":0.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"HCPCS-Q2058","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q2058","description":"HCPCS-Q2058","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":300431.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Injection_ nusinersen_ 0.1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"J2326","description":"Injection_ nusinersen_ 0.1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":135000.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Axicabtage neciloleucel_ up to 200 million autologous anti-CD19 CAR T Cells_ including leukapheresis and dose preparation procedures_ per infusion","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"Q2041","description":"Axicabtage neciloleucel_ up to 200 million autologous anti-CD19 CAR T Cells_ including leukapheresis and dose preparation procedures_ per infusion","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":576345.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Brexucabtagene autoleucel_ up to 200 million autologous anti-cd19 car positive viable t cells_ including leukapheresis and dose preparation procedures_ per therapeutic dose","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"Q2053","description":"Brexucabtagene autoleucel_ up to 200 million autologous anti-cd19 car positive viable t cells_ including leukapheresis and dose preparation procedures_ per therapeutic dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":528759.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Lisocabtagene maraleucel_ up to 110 million autologous anti CAR-positive viable T cells_ including leukapheresis and dose preparation procedures_ per therapeutic dose","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"Q2054","description":"Lisocabtagene maraleucel_ up to 110 million autologous anti CAR-positive viable T cells_ including leukapheresis and dose preparation procedures_ per therapeutic dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":585813.82,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Ciltacabtagene autoleucel_ up to 100 million autologous B-cell maturation antigen (BCMA) dir CAR-positive T cells_ inc leukapheresis and dose prep procs_ per therapeutic dose","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"Q2056","description":"Ciltacabtagene autoleucel_ up to 100 million autologous B-cell maturation antigen (BCMA) dir CAR-positive T cells_ inc leukapheresis and dose prep procs_ per therapeutic dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":600568.24,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Tisagenlecleucel_ up to 600 million car-positive viable t-cells_ including leukopheresis and dose preparation procedures_ per therapeutic dose","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"Q2042","description":"Tisagenlecleucel_ up to 600 million car-positive viable t-cells_ including leukopheresis and dose preparation procedures_ per therapeutic dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":611693.17,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Dialysis procedure","billing_code_type":"CPT","billing_code_type_version":"2024","billing_code":"90999","description":"Dialysis procedure","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"negotiated","negotiated_rate":0.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Idecabtagene Vicleucel_ Up To 460 Million Autologous B-Cell Maturation Antigen (Bcma) Directed Car-Positive T Cells_ Including Leukapheresis And Dose Preparation Procedures_ P","billing_code_type":"HCPCS","billing_code_type_version":"2024","billing_code":"Q2055","description":"Idecabtagene Vicleucel_ Up To 460 Million Autologous B-Cell Maturation Antigen (Bcma) Directed Car-Positive T Cells_ Including Leukapheresis And Dose Preparation Procedures_ P","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":571369.89,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}, {"negotiation_arrangement":"ffs","name":"Anticoagulant management for a patient taking warfarin_ must include review and interpretation of a new home_ office_ or lab international normalized ratio (INR) test result_","billing_code_type":"CPT","billing_code_type_version":"2024","billing_code":"93793","description":"Anticoagulant management for a patient taking warfarin_ must include review and interpretation of a new home_ office_ or lab international normalized ratio (INR) test result_","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"negotiated","negotiated_rate":206.35,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[1329967957]}]}]}